Evaluation study of Meticillin Resistant Staphylococcus aureus (MRSA) during routine nasal decolonisation programmes with Bactroban Nasal ointment, Chlorhexidine Gluconate 4% body and hair wash, and Chlorhexidine Acetate 1% powder and an assessment of adherence to regimen with an analysis of urine

Trial Profile

Evaluation study of Meticillin Resistant Staphylococcus aureus (MRSA) during routine nasal decolonisation programmes with Bactroban Nasal ointment, Chlorhexidine Gluconate 4% body and hair wash, and Chlorhexidine Acetate 1% powder and an assessment of adherence to regimen with an analysis of urine

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2012

At a glance

  • Drugs Mupirocin (Primary) ; Chlorhexidine
  • Indications Methicillin-resistant Staphylococcus aureus infections
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms HT-05
  • Most Recent Events

    • 07 Nov 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 23 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top